Works by Masumoto, Akihide

Results: 27

Hepatocellular Carcinoma Arising from Autoimmune Hepatitis: Report of a Case.

Published in:

Surgery Today, 2007, v. 37, n. 8, p. 716, doi. 10.1007/s00595-007-3483-y

By:

Hidenobu Okino;
Takeaki Satoh;
Jiro Watanabe;
Akihide Masumoto;
Shigeaki Takeda

Publication type:

Article

Recurrent Subcutaneous Abscess of the Sternal Region in Ulcerative Colitis.

Published in:

American Journal of Gastroenterology (Springer Nature), 1999, v. 94, n. 3, p. 844, doi. 10.1111/j.1572-0241.1999.00957.x

By:

Murata, Ikuo;
Satoh, Kei;
Yoshikawa, Ichiro;
Masumoto, Akihide;
Sasaki, Ei;
Otsuki, Makoto

Publication type:

Article

High Plasma Concentrations of Nitrite/Nitrate in Patients with Hepatocellular Carcinoma.

Published in:

American Journal of Gastroenterology (Springer Nature), 1997, v. 92, n. 9, p. 1520

By:

Moriyama, Atsushi;
Masumoto, Akihide;
Nanri, Hiroki;
Tabaru, Akinari;
Unoki, Hideaki;
Imoto, Issei;
Ikeda, Masaharu;
Otsuki, Makoto

Publication type:

Article

TRANSIENT MULTIPLE HEPATIC NODULES WITH MARKED INFILTRATION OF EOSINOPHILS CAUSED BY ASCARIASIS.

Published in:

American Journal of Gastroenterology (Springer Nature), 1997, v. 92, n. 5, p. 897

By:

Arao, Shuichi;
Masumoto, Akihide;
Unoki, Hideaki;
Tabaru, Akirari;
Kotoh, Kazuhiro;
Otsuki, Makoto

Publication type:

Article

CASE REPORT: Haemothorax due to hepatocellular carcinoma rupture successfully controlled by transcatheter arterial embolization.

Published in:

Journal of Gastroenterology & Hepatology, 1997, v. 12, n. 2, p. 156, doi. 10.1111/j.1440-1746.1997.tb00399.x

By:

MASUMOTO, AKIHIDE;
MOTOMURA, KENTA;
UCHIMURA, KOUTARO;
MOROTOMI, IKUO;
MORITA, KAZUNORI

Publication type:

Article

Risk factors for loss to follow‐up after the start of direct‐acting antiviral treatment for hepatitis C virus infection.

Published in:

JGH Open, 2023, v. 7, n. 2, p. 98, doi. 10.1002/jgh3.12855

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Kurosaka, Kazuki;
Tanaka, Kosuke;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group

Published in:

Journal of Gastroenterology & Hepatology, 2008, v. 23, n. 7pt1, p. 1094, doi. 10.1111/j.1440-1746.2008.05319.x

By:

Furusyo, Norihiro;
Kajiwara, Eiji;
Takahashi, Kazuhiro;
Nomura, Hideyuki;
Tanabe, Yuichi;
Masumoto, Akihide;
Maruyama, Toshihiro;
Nakamuta, Makoto;
Enjoji, Munehika;
Azuma, Koichi;
Shimono, Junya;
Sakai, Hironori;
Shimoda, Shinji;
Hayashi, Jun

Publication type:

Article

Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients.

Published in:

Comparative Hepatology, 2007, v. 6, p. 3, doi. 10.1186/1476-5926-6-3

By:

Nakamuta, Makoto;
Kotoh, Kazuhiro;
Enjoji, Munechika;
Kajiwara, Eiji;
Shimono, Junya;
Masumoto, Akihide;
Maruyama, Toshihiro;
Furusyo, Norihiro;
Nomura, Hideyuki;
Sakai, Hironori;
Takahashi, Kazuhiro;
Azuma, Koichi;
Shimoda, Shinji;
Tanabe, Yuichi;
Hayashi, Jun

Publication type:

Article

Hepatitis C virus eradication ameliorates the prognosis of advanced hepatocellular carcinoma treated with sorafenib.

Published in:

Journal of Viral Hepatitis, 2022, v. 29, n. 7, p. 543, doi. 10.1111/jvh.13681

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Nagasawa, Shigehiro;
Tanaka, Kosuke;
Morita, Yusuke;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment.

Published in:

Journal of Viral Hepatitis, 2022, v. 29, n. 1, p. 35, doi. 10.1111/jvh.13625

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Nagasawa, Shigehiro;
Tanaka, Kosuke;
Morita, Yusuke;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39858-8

By:

Ito, Shuji;
Liu, Xiaoxi;
Ishikawa, Yuki;
Conti, David D.;
Otomo, Nao;
Kote-Jarai, Zsofia;
Suetsugu, Hiroyuki;
Eeles, Rosalind A.;
Koike, Yoshinao;
Hikino, Keiko;
Yoshino, Soichiro;
Tomizuka, Kohei;
Horikoshi, Momoko;
Ito, Kaoru;
Uchio, Yuji;
Momozawa, Yukihide;
Kubo, Michiaki;
Masumoto, Akihide;
Nagai, Akiko;
Obata, Daisuke

Publication type:

Article

Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study.

Published in:

In Vivo, 2024, v. 38, n. 4, p. 1854, doi. 10.21873/invivo.13639

By:

AKIFUMI KUWANO;
MASAYOSHI YADA;
KOSUKE TANAKA;
YUTA KOGA;
SHIGEHIRO NAGASAWA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

Accordion Index: A new tool for the prediction of the efficacy of peg-interferon-α-2b and ribavirin combination therapy for chronic hepatitis C.

Published in:

Hepatology Research, 2008, v. 38, n. 3, p. 315, doi. 10.1111/j.1872-034X.2007.00272.x

By:

Satoh, Takeaki;
Masumoto, Akihide

Publication type:

Article

Body surface area is an independent factor contributing to the effects of lamivudine treatment

Published in:

Hepatology Research, 2005, v. 31, n. 1, p. 13, doi. 10.1016/j.hepres.2004.11.004

By:

Nakamuta, Makoto;
Kotoh, Kazuhiro;
Tanabe, Yuichi;
Kajiwara, Eiji;
Shimono, Junya;
Masumoto, Akihide;
Maruyama, Toshihiro;
Furusyo, Norihiro;
Nomura, Hideyuki;
Sakai, Hironori;
Takahashi, Kazuhiro;
Azuma, Koichi;
Shimoda, Shinji;
Enjoji, Munechika;
Hayashi, Jun

Publication type:

Article

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial.

Published in:

2017

By:

Kudo, Masatoshi;
Hatano, Etsuro;
Ohkawa, Shinichi;
Fujii, Hirofumi;
Masumoto, Akihide;
Furuse, Junji;
Wada, Yoshiyuki;
Ishii, Hiroshi;
Obi, Shuntaro;
Kaneko, Shuichi;
Kawazoe, Seiji;
Yokosuka, Osamu;
Ikeda, Masafumi;
Ukai, Katsuaki;
Morita, Sojiro;
Tsuji, Akihito;
Kudo, Toshihiro;
Shimada, Mitsuo;
Osaki, Yukio;
Tateishi, Ryosuke

Publication type:

journal article

Systemic Chemotherapy for Advanced Hepatocellular Carcinoma in Patients With Child-Pugh class B.

Published in:

Cancer Diagnosis & Prognosis, 2024, v. 4, n. 2, p. 111, doi. 10.21873/cdp.10295

By:

AKIFUMI KUWANO;
MASAYOSHI YADA;
KOSUKE TANAKA;
YUTA KOGA;
SHIGEHIRO NAGASAWA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

Neutrophil-to-Lymphocyte Ratio Predicts Immune-related Adverse Events in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

Published in:

Cancer Diagnosis & Prognosis, 2024, v. 4, n. 1, p. 34, doi. 10.21873/cdp.10282

By:

AKIFUMI KUWANO;
MASAYOSHI YADA;
KOSUKE TANAKA;
YUTA KOGA;
SHIGEHIRO NAGASAWA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

Combined Ultrasound and Computed Tomography Guidance in Radiofrequency Ablation for Hepatocellular Carcinoma Reduces Local Recurrence Rate.

Published in:

Cancer Diagnosis & Prognosis, 2023, v. 3, n. 6, p. 660, doi. 10.21873/cdp.10269

By:

SHIGEHIRO NAGASAWA;
AKIFUMI KUWANO;
KOSUKE TANAKA;
MASAYOSHI YADA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Published in:

Cancer Diagnosis & Prognosis, 2023, v. 3, n. 4, p. 468, doi. 10.21873/cdp.10241

By:

AKIFUMI KUWANO;
MASAYOSHI YADA;
YOSHIKO MIYAZAKI;
KOSUKE TANAKA;
YUTA KOGA;
YOSHIHIRO OHISHI;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies.

Published in:

Hepatology Research, 2016, v. 46, n. 10, p. 992, doi. 10.1111/hepr.12638

By:

Okanoue, Takeshi;
Shima, Toshihide;
Hasebe, Chitomi;
Karino, Yoshiyasu;
Imazeki, Fumio;
Kumada, Takashi;
Minami, Masahito;
Imai, Yasuharu;
Yoshihara, Harumasa;
Mita, Eiji;
Morikawa, Teruhisa;
Nishiguchi, Shuhei;
Kawakami, Yoshiiku;
Nomura, Hideyuki;
Sakisaka, Shotaro;
Kurosaki, Masayuki;
Yatsuhashi, Hiroshi;
Oketani, Makoto;
Kohno, Hiroshi;
Masumoto, Akihide

Publication type:

Article

Therapeutic efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma with WNT/β-catenin signal activation.

Published in:

Oncology Letters, 2022, v. 24, n. 1, p. N.PAG, doi. 10.3892/ol.2022.13337

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Narutomi, Fumiya;
Nagasawa, Shigehiro;
Tanaka, Kosuke;
Kurosaka, Kazuki;
Ohishi, Yoshihiro;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Therapeutic efficacy of lenvatinib for hepatocellular carcinoma with iso-high intensity in the hepatobiliary phase of Gd-EOB-DTPA-MRI.

Published in:

Molecular & Clinical Oncology, 2022, v. 16, n. 2, p. 1, doi. 10.3892/mco.2021.2486

By:

AKIFUMI KUWANO;
KOSUKE TANAKA;
MASAYOSHI YADA;
SHIGEHIRO NAGASAWA;
YUSUKE MORITA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

Diagnostic features of autoimmune hepatitis in SARS-CoV-2-vaccinated vs. unvaccinated individuals.

Published in:

Experimental & Therapeutic Medicine, 2024, v. 28, n. 3, p. 1, doi. 10.3892/etm.2024.12626

By:

AKIFUMI KUWANO;
SHIGEHIRO NAGASAWA;
YUTA KOGA;
KOSUKE TANAKA;
MASAYOSHI YADA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy.

Published in:

Experimental & Therapeutic Medicine, 2023, v. 26, n. 3, p. N.PAG, doi. 10.3892/etm.2023.12140

By:

Kuwano, Akifumi;
Miyazaki, Masayuki;
Yada, Masayoshi;
Tanaka, Kosuke;
Koga, Yuta;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice.

Published in:

Cancers, 2023, v. 15, n. 17, p. 4345, doi. 10.3390/cancers15174345

By:

Motomura, Kenta;
Kuwano, Akifumi;
Tanaka, Kosuke;
Koga, Yuta;
Masumoto, Akihide;
Yada, Masayoshi

Publication type:

Article

Dynamics of the neutrophil‑to‑lymphocyte ratio during lenvatinib treatment for unresectable hepatocellular carcinoma.

Published in:

Oncology Letters, 2024, v. 28, n. 1, p. N.PAG, doi. 10.3892/ol.2024.14442

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Koga, Yuta;
Tanaka, Kosuke;
Ohishi, Yoshihiro;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Tumor‑infiltrating CD8<sup>+</sup> T cells as a biomarker for chemotherapy efficacy in unresectable hepatocellular carcinoma.

Published in:

Oncology Letters, 2023, v. 25, n. 6, p. N.PAG, doi. 10.3892/ol.2023.13845

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Miyazaki, Yoshiko;
Tanaka, Kosuke;
Kurosaka, Kazuki;
Ohishi, Yoshihiro;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article